Eli Lilly to buy gene therapy biotech Prevail for $1.04B
Eli Lilly to buy gene therapy biotech Prevail for $1.04B By (0) The companies said the deal will maximize efforts to bring gene therapies to a wider audience. File Photo by Wikimedia Commons/UPI Dec. 15 (UPI) -- Pharmaceutical company Eli Lilly announced Tuesday that it has agreed to buy gene therapy biotech Prevail for more than $1 billion. As part of the deal, Eli Lilly will buy Prevail stock for $22.50 in cash, representing a premium of 80% to Mondays closing price. Advertisement Prevail d...
Source: upi.com